Teresa O. Lipcsey, Cpa, Cgma
About Teresa O. Lipcsey, Cpa, Cgma
Teresa O. Lipcsey is a seasoned accounting and finance professional currently serving as the VP of Accounting & Finance at Wave Life Sciences. With extensive experience in budgeting, financial reporting, and compliance, she has held key positions in various organizations, including Immunicon Corporation and Axogen.
Current Role at Wave Life Sciences
Teresa O. Lipcsey serves as the Vice President of Accounting & Finance at Wave Life Sciences, a position she has held since 2021. Based in Cambridge, Massachusetts, she oversees financial operations and strategic financial planning. Her role involves implementing financial processes that enhance corporate value and ensuring compliance with regulatory standards.
Previous Experience in Accounting and Finance
Prior to her current role, Lipcsey held several key positions in various organizations. She was the VP and Chief Accounting Officer at Immunicon Corporation from 2003 to 2008, where she also served as Controller. At MEDIQ, she worked as a Financial Reporting Accountant from 1991 to 1995. Additionally, she was the VP, Corporate Controller at Axogen from 2019 to 2021 and the VP of Finance at Invisible Sentinel, Inc. in 2014.
Educational Background in Accounting and Finance
Lipcsey earned her Bachelor of Science degree in Accounting and Finance from the University of Maryland, where she studied from 1983 to 1988. This educational foundation has equipped her with the knowledge and skills necessary for her extensive career in finance and accounting.
Expertise in Financial Management
Lipcsey possesses expertise in various areas of financial management, including budgeting, forecasting, and systems implementation. She has demonstrated leadership in strategic planning, acquisition integration, and due diligence processes. Her proficiency extends to cash management, working capital optimization, and risk management, including foreign exchange strategies.
Experience with Regulatory Compliance
Lipcsey has a strong background in Sarbanes-Oxley (SOX) 404 compliance and audit processes. She is experienced in managing SEC filings and financial reporting, ensuring adherence to regulatory standards. Her extensive experience includes handling multiple IPOs, mergers, and acquisitions across industries such as technology, medical devices, and biotech.